Algernon Pharmaceuticals Inc C.AGN

AGN.c has been granted Orphan Drug Designation to Ifenprodil

[stockpatrol]

AGN.c has been granted Orphan Drug Designation to Ifenprodil for treatment of Pulmonary fibrosis. 

 

https://ca.finance.yahoo.com/news/algernon-pharmaceuticals-receives-u-fda-120000269.html

 

Recently completing phase 2 study on Ifenprodil in patients showed no worsening of lung function and significant improvements were seen. 

 

. “This regulatory milestone comes at an important time in the development of Ifenprodil as a potential new therapy for IPF, as we plan the next steps for our clinical program.”

 

AGN.c looking strong closing up 22% today surpassing the $3 mark.

[XeniaTechie]

Major catalyst alert re: Algernon’s recent news being granted orphan drug designation by the FDA for its use of Ifenprodil as a treatment for IPF. FDA orphan drug designation is massive due to the potential 7-year exclusivity following approval. Can't wait for the next updates as they progress through the next steps of their clinical program.